Could a cancer drug tame dangerous brain vessels?
NCT ID NCT06264531
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the drug bevacizumab, given through a vein, can improve symptoms like headaches, seizures, and thinking problems in people with brain arteriovenous malformations (AVMs) that are too large or risky for surgery or radiation. About 54 adults with moderate to severe symptoms will receive the drug to see if it reduces their disability. The goal is symptom control, not a cure, and participants may still need other treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL AV MALFORMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
HFAR
RECRUITINGParis, Île-de-France Region, 75019, France